The Client – an overview
It is part of a multinational conglomerate, well-known in the biopharmaceutical domain for the critical role it plays in manufacturing life-saving medical formulations for diabetes and cardiovascular conditions in particular. As the organization handled important data every single day, from classified research to sensitive patient information, it was among the favorite targets for cyber criminals. Recognizing the importance of robust cybersecurity, the organization wanted to enhance its IT and security infrastructure.
Background and Key Challenges
The biopharmaceutical industry, responsible for cutting-edge research and manufacturing of medications to save human lives and improve their quality of life, is facing growing cybersecurity threats amid its digital transformation journey. Due to the growing reliance of these organizations on digital technologies, they have become vulnerable to cybersecurity risks, leading to disruption in operations, loss of sensitive information due to data breaches, financial loss and reputational damage. Being cash-rich, with sensitive patient data and intellectual property, these organizations in the pharma sector are an easy target for ransomware hackers. Malicious attachments are sent, which freeze and encrypt files and computers when downloaded, and the attackers demand huge compensation in exchange for the decryption key. This pharmaceutical organization recognized the urgent need to enhance its IT and security infrastructure with a focus on deploying an Endpoint Detection and Response (EDR) solution strategically across to ensure resilience against the evolving cyber threats.
The Challenges the pharmaceutical organization faced were,
- Targeted Ransomware Attacks: There were growing attempts from sophisticated threat actors targeting high-value research, patient and operational data.
- Lack of Visibility: The security teams faced difficulties in early detection, containment, and mitigation of threats.
- Absence of EDR Integration: Legacy infrastructure lacked the integration of advanced endpoint security solutions, leaving gaps in proactive defense and automated response.
- Operational Downtime and Business Disruption: Security incidents risked disrupting manufacturing, business operations and regulatory compliance requirements and timelines.
- To eradicate ransomware footprints and malicious tools across the organization’s IT infrastructure.
- To strengthen the organization’s security posture and ransomware resilience while eliminating any malicious footprints.
- To establish better threat visibility across all endpoints for faster identification of threats and faster containment.
- To ensure seamless integration of the EDR solution within the existing IT and security environment.
- To reduce the attack surface for any ransomware and malicious infections.
The Solution: Inspira Enterprise Approach
To address the challenges and achieve the above goals, the pharmaceutical organization partnered with Inspira Enterprise, a global cybersecurity risk management service provider with deep experience in implementing large-scale cybersecurity deployment programs. The team of experts from Inspira followed a structured and phased approach as follows,
- Comprehensive Gap Analysis
- At the outset, the team conducted an in-depth assessment of the pharmaceutical organization’s current environment.
- It designed a structured EDR implementation strategy with minimal turnaround time.
- Tailored Security Policies
- Customized policies were built to ensure effective removal of malicious components and footprints.
- The team reinforced the integrity and resilience of the operational environment.
- Proactive Threat Hunting and Patch Management
- Advanced threat hunting measures were developed and implemented to detect sophisticated attacks.
- By implementing comprehensive patch management, the dwell time across the network was reduced significantly.
- Early Attack Identification Strategy
- The team implemented strategies and policies that enabled early detection and attack attempts.
- All critical, manufacturing and regulatory data were protected from being compromised.
- EDR Deployment and Integration
- The team rolled out robust EDR solutions across all endpoints.
- Seamless integration with existing SOC, SIEM and legacy systems ensured the elimination of business disruption.
Outcomes and Benefits
The engagement between the pharmaceutical organization and Inspira Enterprise delivered measurable improvements in visibility, resilience, compliance, and operational efficiency.
Enhanced Ransomware Defense
Rapid containment and eradication of ransomware footprints and malicious tools were achieved before they had any impact on the organization.
Improved Threat Visibility
Across all endpoints, real-time monitoring and early identification of malicious activities were enhanced.
Strengthened Security Posture
Through the enforcement of role-based policies and post-remediation validation, the organization’s security posture was strengthened, ensuring resilience and preventing future financial and data loss.
Streamlined Integration
The EDR solution seamlessly integrated into the organization’s IT and security ecosystem.
Reduced Dwell Time and Downtime
Proactive threat hunting and patch management significantly reduced dwell time, while the automated, early response mechanisms decreased the downtime, ensuring business continuity and continuous production.
Reduced Attack Surface
The team ensured the attack surface was reduced, minimizing opportunities for ransomware and malicious infections, boosting long-term defense.
About Inspira Enterprise
Inspira Enterprise is a global Cybersecurity, Data Analytics, and Artificial Intelligence services provider with a presence in North America, ASEAN, the Middle East, Africa, and India. It delivers adaptive, intelligent, and customer-centric solutions to various industries, including Banking, Financial Services, and Insurance (BFSI), Healthcare, Public Sector, Manufacturing, Education, Oil and Gas, and Utilities.
The organization’s expertise in AI-driven cybersecurity enables comprehensive protection against evolving cyber threats to help protect enterprises. It leverages advanced analytics and AI-powered threat detection to offer real-time visibility and proactive risk management, strengthening organizational security. At the core of Inspira’s offerings is iSMART2—an advanced AI-driven platform delivering continuous monitoring, analytics, and actionable insights to mitigate risks and stay ahead of emerging threats.
With 1600+ professionals, Inspira successfully delivers complex transformation projects for 550+ clients. Its AI and cybersecurity capabilities empower businesses to build resilient, future-ready digital ecosystems. Learn more: www.inspiraenterprise.com.
